During the past decade, Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia" are "Multiple Sclerosis" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Crenezumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".